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1. Introduction 
DNA methylation of CpG dinucleotides is essential for mammalian development, X 
inactivation, genomic imprinting, and may also be involved in immobilization of transposons 
and the control of tissue-specific gene expression (Bird & Wolffe, 1999). The common theme in 
each of these processes is gene silencing. Therefore, gene silencing is a major biological 
consequence of DNA methylation. As such, DNA methylation can play a very important role 
in human disease. For example, DNA methylation-induced silencing of tumour suppressor 
genes can result in cancer, while gain or loss of DNA methylation can produce loss of genomic 
imprinting in diseases such as Beckwith-Wiedermann syndrome (BWS), Prader-Willi 
syndrome (PWS) or Angelman syndrome (AS) (Robertson, 2005). Yet another group of 
diseases where DNA methylation has a prominent role to play in disease aetiology and 
pathology is that of the inherited trinucleotide repeat (TNR) expansion diseases. 
TNR expansion diseases can be divided into two major subgroups: (i) those involving large 
non-coding repeats (typically 100-1000 repeats), and (ii) those involving short coding repeats 
(< 100 repeats, coding for polyglutamine or polyalanine). The majority of TNR expansion 
diseases that have disease-associated DNA hypermethylation are of the large non-coding 
repeat type. These include fragile X syndrome (FRAXA), which is caused by CGG repeat 
expansion in the 5-untranslated region (UTR) of the FMR1 gene (Verkerk et al., 1991), 
myotonic dystrophy type I (DM1), which is caused by CTG repeat expansion in the 3-UTR of 
the DMPK gene (Brook et al., 1992), and Friedreich ataxia (FRDA), which is caused by GAA 
repeat expansion within intron 1 of the FXN gene (Campuzano et al., 1996). However, there is 
also evidence for possible involvement of DNA methylation in the short CAG repeat, 
polyglutamine-encoding, types of TNR expansion diseases, such as spinocerebellar ataxia type 
1 (SCA1) (Dion et al., 2008) and spinocerebellar ataxia type 7 (SCA7) (Libby et al., 2008). 
This review focuses on recent advances in our understanding of DNA methylation 
association with inherited TNR expansion diseases. It first describes the relevant TNR 
expansion diseases, the genes that are mutated and what is currently known about DNA 
methylation profiles in each case. This is followed by consideration of the potential causes of 
DNA methylation, the subsequent effects of DNA methylation on disease phenotype, and 
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how understanding the mechanisms of DNA methylation may benefit efforts towards 
therapy for TNR expansion diseases. 
2. TNR expansion diseases with associated DNA methylation 
2.1 Fragile site-related mental retardation syndromes  
Seven folate-sensitive fragile sites have been identified within human chromosomes: 
FRAXA (Verkerk et al., 1991), FRAXE (Knight et al., 1993), FRAXF (Parrish et al., 1994), 
FRA10A (Sarafidou et al., 2004), FRA11B (Jones et al., 1995), FRA12A (Winnepenninckx et 
al., 2007) and FRA16A (Nancarrow et al., 1994) (Table 1). In each case, the fragile site is 
associated with a large non-coding CGG repeat expansion, together with methylation of the 
CpG sites within the repeat expansion as well as within an adjacent upstream CpG island 
(Lopez Castel et al., 2010a). In the majority of cases, the CGG repeat expansion occurs within 
the 5-UTR of a specific gene and the CpG island resides within the promoter region of this 
gene (Table 1). The effect of DNA methylation is to induce silencing of the gene, and the 
outcome of this, for the majority of fragile site-expressing patients, is the development of 
mental retardation. 
 
Disease Fragile site 
Chromosomal 
position 
Associated Gene
CGG repeat size 
Normal Disease 
FRAXA Fragile X 
syndrome 
FRAXA Xq27.3 FMR1 6-54 >200 
FRAXE Fragile X 
syndrome 
FRAXE Xq28 FMR2 4-39 >200 
None identified at 
present 
FRAXF Xq28 FAM11A 7-40 >300 
None identified at 
present 
FRA10A 10q23.3 FRA10AC1 8-14 >200 
Jacobsen 
syndrome 
FRA11B 11q23.3 
CBL2
(candidate) 
11 >100 
Mental 
retardation 
FRA12A 12q13.1 DIP2B 6-23 >150 
None identified at 
present 
FRA16A 11q22 Unknown 16-49 >1000 
Table 1. Fragile sites that are associated with aberrant methylated, expanded CGG repeats 
and methylated adjacent CpG sites in disease state. 
2.1.1 Fragile X syndrome (FRAXA) 
The most prominent of the fragile site disorders is Fragile X syndrome (FRAXA), an X linked 
disorder that is recognized as the most common inherited form of mental retardation 
(Brouwer et al., 2009). FRAXA is caused by CGG repeat expansion within the 5 UTR of the 
FMR1 (fragile X mental retardation 1) gene, which is located at the FRAXA fragile site on 
chromosome Xq27.3 (Verkerk et al., 1991) (Fig. 1). Unaffected individuals have a range of 
allele sizes between 6-54 CGG repeats. However, allele sizes of 55-200 CGG repeats, known 
as ‘premutations’, are unstable and can expand upon transmission to FRAXA individuals, 
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who have alleles that exceed 200 CGG repeats, known as ‘full mutations’ (Fu et al., 1991). 
The expanded CGG repeats become methylated, as does the CpG island within the FMR1 
promoter, resulting in reduced expression of the FMR1 gene product FMRP during 
development. Detailed analysis of the FMR1 gene has revealed a distinct boundary of DNA 
methylation at a site between 650 and 800 nucleotides upstream of the CGG repeat in 
unaffected individuals that is lost in FRAXA patients (Naumann et al., 2009). This suggests 
that the FMR1 promoter is normally protected from the spread of DNA methylation by a 
specific chromatin structure, which is somehow removed as a consequence of the expanded 
CGG repeat sequence. 
Premutation CGG repeats ranging in size from 55-200 do not induce the typical DNA 
methylation and gene silencing that is seen with full mutations. Instead, unmethylated 
premutation CGG repeats produce overexpression of the FMR1 gene, resulting in a toxic 
gain-of-function RNA that gives rise to the phenotypically distinct disorder called fragile X 
tremor/ataxia syndrome (FXTAS) (Jacquemont et al., 2003). 
 
Fig. 1. Location of DNA methylation within expanded TNR loci. (A) FRAXA: The expanded 
CGG repeat is located in the 5’-UTR of the FMR1 gene. A boundary of DNA methylation 
associated with normal CGG alleles (light grey box) shifts upon CGG expansion to enclose 
the CGG repeat  (dark grey box). (B) DM1: The expanded CTG repeat in the 3’-UTR of the 
DMPK gene, and (C) FRDA: The expanded GAA repeat in intron 1 of the FXN gene are each 
associated with regions of DNA methylation just upstream of the expanded repeat. 
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2.2 Myotonic Dystrophy type 1 (DM1) 
Myotonic dystrophy type 1 (DM1) is an autosomal dominant inherited multisystem disorder 
characterized by clinical features such as muscle weakness, myotonia and heart conduction 
defects (Schara & Schoser, 2006). The molecular basis for DM1 is expansion of a CTG repeat 
sequence within the 3-UTR of the DMPK gene (Brook et al., 1992). Unaffected individuals 
have CTG repeat sizes of 5-37, and there is a premutation range of 34-90 CTG repeats, 
whereas affected individuals have expanded CTG repeat sizes that can range from 90 to 
thousands of units (Lopez Castel et al., 2010a). Both intergenerational and somatic instability 
of the CTG repeat are evident, providing a molecular basis for the anticipation phenomenon 
observed in DM1 families, together with tissue specific differences in disease pathology 
(Lavedan et al., 1993; Monckton et al., 1995). The effects of expanded CTG repeats are two-
fold. Firstly, expression of an expanded CUG RNA sequence causes a toxic gain-of-function 
effect by altering the activity of RNA splicing factors (Ranum & Cooper, 2006). Secondly, the 
expanded CTG repeat induces epigenetic changes, including DNA methylation, at the DM1 
locus that result in reduced expression of the DMPK gene and upstream and downstream 
genes SIX5 and DMWD (Klesert et al., 1997; Alwazzan et al., 1999; Eriksson et al., 2001). 
Disease-associated DNA methylation was first reported to occur within a region 
approximately 1kb upstream of the DMPK gene (Steinbach et al., 1998). However, this was a 
rather restricted study based on the use of methylation-sensitive restriction enzymes that do 
not identify all CpG sites. A more recent study, which used bisulphite sequencing to 
characterize the DM1 locus at higher resolution, confirmed the disease-associated DNA 
methylation upstream of the expanded CTG repeat and further identified a distinct 
boundary at the expanded CTG repeat beyond which there is no DNA methylation (Lopez 
Castel et al., 2010b) (Fig.1). 
2.3 Friedreich Ataxia (FRDA) 
Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disorder caused by 
homozygous GAA repeat expansion within intron 1 of the FXN gene (Campuzano et al., 
1996). The effect of the expanded GAA repeat is to reduce expression of the essential 
mitochondrial protein frataxin (Campuzano et al., 1997), which results in progressive 
spinocerebellar neurodegeneration and cardiomyopathy (Pandolfo, 2009). Unaffected 
individuals have FXN alleles containing 5-32 GAA repeats, there is a premutation range of 
33-65 GAA repeats, and affected individuals have alleles of 66-1700 GAA repeats. Both 
intergenerational and somatic instability of the GAA repeat are evident in FRDA, with 
expanded GAA repeats occurring prominently in disease-related CNS tissue (De Michele et 
al., 1998; De Biase et al., 2007a, 2007b). There is no disease-associated change in the DNA 
methylation status of the CpG island that spans the FXN 5-UTR and exon 1 regions. 
However, disease-associated DNA hypermethylation has been identified within a region of 
FXN intron 1 immediately upstream of the expanded GAA repeat in FRDA cell culture, 
FRDA patient tissues and FRDA mouse models (Greene et al., 2007; Al-Mahdawi et al., 
2008). Furthermore, the level of DNA methylation in this region correlates with expanded 
GAA repeat size and inversely correlates with age of FRDA disease onset (Castaldo et al., 
2008). Interestingly, DNA hypomethylation has been identified in the FXN intron 1 Alu 
repeat sequence (which is normally fully methylated) immediately downstream of the 
expanded GAA repeat (Al-Mahdawi et al., 2008) (Fig.1). This effect of demethylation may 
have some, as yet unknown, relevance for GAA repeat instability and frataxin expression. 
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2.4 Polyglutamine-encoding TNR expansion disorders 
To date, eleven inherited disorders are known to be caused by expansion of CAG repeats 
within the coding region of genes, resulting in the production of abnormal proteins that 
have long stretches of polyglutamine repeats (Lopez Castel et al., 2010a). Included within 
this group of polyglutamine disorders are Huntington disease (HD) and the spinocerebellar 
ataxias (SCAs). In each case, the severity of disease correlates with the size of the expanded 
CAG repeat, which is subject to both intergenerational and somatic instability (Koefoed et 
al., 1998; Wheeler et al., 2007). There is currently no evidence to support a disease-associated 
role for DNA methylation in HD (Reik et al., 1993) or SCA3 (Emmel et al., 2011). However, 
DNA methylation has been implicated in stability of CAG repeats in SCA1 (Dion et al., 2008) 
and in increased instability of CAG repeats in SCA7 (Libby et al., 2008). 
3. Causes of DNA methylation 
DNA methylation is involved in human diseases such as cancer, imprinting disorders and 
inherited TNR disorders, but at present it is not known why certain CpG sequences 
succumb to disease-associated aberrant DNA methylation. When considering the causes of 
DNA methylation in the TNR disorders, distinction must be made between DNA 
methylation of the expanded CGG repeat itself in the fragile site disorders, such as FRAXA 
and FRAXE, and DNA methylation of the flanking CpG sites in both fragile site disorders 
and other TNR disorders, including DM1 and FRDA. In the case of expanded CGG repeat 
disorders, the CGG repeat contains CpG residues that may be subject to methylation by 
direct effects. Thus, expanded CGG repeats have been shown to form single-stranded 
hairpins that lead to slippage structures during replication. Unrepaired slippage structures 
that contain extrahelical and mispaired cytosines may then act as substrates for direct de 
novo methylation by DNA methyltransferase enzymes (Chen et al., 1995; Laayoun & Smith, 
1995; Chen et al., 1998). On the other hand, a common theme for all of the large non-coding 
TNR expansion diseases is DNA hypermethylation of CpG dinucleotides in the local vicinity 
of the TNR expansion. This suggests the action of a unified, but as yet unknown, secondary 
molecular mechanism. Evidence in favour of both cis- and trans-acting secondary effects has 
been put forward. Thus, aberrant DNA methylation of expanded CGG repeats or CpG 
sequences flanking expanded TNR sequences may be based upon underlying cis-acting 
DNA sequence context. For example, there is evidence to suggest that methylation can 
spread from core repetitive DNA sequences (Yates et al., 1999), and particular motifs have 
been identified as candidates for methylation-targeting DNA sequences (Feltus et al., 2006).  
Another potential mechanism, which could be either cis- or trans-acting, is the induction of 
DNA methylation by short interfering RNAs (siRNAs). Studies of human cells have shown 
that long CNG repeat hairpins can be cleaved by the ribonuclease Dicer to form short 
double-stranded siRNAs (Krol et al., 2007), which may then induce DNA methylation as a 
process of transcriptional gene silencing (Kawasaki & Taira, 2004; Morris et al., 2004). 
Bidirectional transcription across TNRs may also produce siRNAs, which then recruit 
histone methyltransferases, HP1 and DNA methyltransferases to result in DNA 
methylation, as proposed for a general model of heterochromatin formation at repetitive 
elements (Grewal & Jia, 2007). Alternatively, siRNAs targeted to gene promoter CpG islands 
may be produced by bidirectional transcription at these regions (Morris et al., 2008), and 
such bidirectional transcripts have indeed been identified at several TNR loci (Cho et al., 
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2005; Moseley et al., 2006; Ladd et al., 2007; De Biase et al., 2009; Chung et al., 2011). 
Furthermore, DNA methylation at the TNR locus may be induced by trans-acting siRNAs 
that are generated from a different locus (Watanabe et al., 2011). In each case, DNA 
methylation is likely to be a later long-term gene silencing effect, following on from earlier 
increases in histone methylation (Hawkins et al., 2009). Interestingly, siRNA targeting of the 
huntingtin gene promoter has failed to induce DNA methylation (Park et al., 2004), agreeing 
with a lack of any evidence for DNA methylation induction by CAG repeat expansion (Reik 
et al., 1993).  
Another general mechanism that may be involved in the formation of DNA methylation at 
TNR loci is the loss of a methylation-sensitive chromatin insulator and subsequent 
spreading of DNA methylation. Of particular note is the chromatin insulator protein CTCF 
(CCCTC-binding protein), since CTCF binding sites have been identified in the flanking 
regions of FRAXA CGG repeats (Ladd et al., 2007), DM1 CTG repeats (Filippova et al., 2001) 
and SCA7 CAG repeats (Libby et al., 2008), and also in the upstream region of FXN GAA 
repeats (De Biase et al., 2009) (Fig.2). 
 
Fig. 2. The position of CTCF binding sites within TNR expansion loci (A) FRAXA, (B) DM1, 
(C) SCA7 and (D) FRDA. Grey boxes represent regions of DNA methylation. 
A model has been proposed for the DM1 locus whereby the normal CTG repeat allele is 
associated with bidirectional transcription, siRNAs, H3K9 dimethylation and HP1 
recruitment in the region of the CTG repeats, but without any associated DNA methylation. 
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This local heterochromatin formation is limited to a small region by flanking CTCF sites and 
it is likely that CTCF binding protects the DM1 CTG region from DNA methylation. 
However, expanded DM1 CTG repeats are associated with loss of CTCF binding, spread of 
heterochromatin and regional CpG methylation (Cho et al., 2005). In FRDA, expanded GAA 
repeats are similarly associated with depletion of CTCF binding in the 5-UTR of the FXN 
gene and associated hypermethylation of CpG sites just upstream of the GAA repeat.  
(Greene et al., 2007; Al-Mahdawi et al., 2008; De Biase et al., 2009). However, it is not 
currently known if depletion of CTCF actually precedes DNA methylation, or vice versa, in 
the context of TNR expansion diseases. For example, DNA methylation is known to inhibit 
CTCF binding at the DM1 locus and other genetic loci (Filippova, 2008), whereas it does not 
appear to inhibit CTCF binding at the FXN locus (De Biase et al., 2009). Therefore, further 
studies will be required to determine the precise order of events that connect TNR 
expansions, CTCF binding and DNA methylation. 
4. Effects of DNA methylation 
There are two principal effects of DNA methylation on TNR expansion disorders. Firstly, 
silencing of gene transcription may take place, exerting profound effects on the subsequent 
disease phenotype. Secondly, modulation of TNR instability may occur throughout 
development and within different specific tissues, which will also impact upon progression 
of the disease phenotype. 
4.1 Silencing of gene expression 
The main effect of DNA methylation in TNR expansion disorders, as with other diseases 
such as cancer, is silencing of gene transcription. DNA methylation inhibits transcription by 
two general mechanisms: (i) preventing binding of basal transcription proteins or other 
regulatory DNA binding proteins (e.g. CTCF), and (ii) influencing nucleosome positioning 
or stability and reinforcing heterochromatin formation through the actions of methyl-CpG-
binding proteins (MBPs), histone modifications and chromatin remodeling (Klose & Bird, 
2006). There is evidence for both mechanisms at play in silencing of gene transcription in 
TNR expansion disorders. For FRAXA, expansion of CGG repeats in the 5-UTR of the FMR1 
gene to greater than 200 units induces CpG methylation within the repeat tract and also the 
adjacent promoter region, leading to transcriptional silencing (Pieretti et al., 1991; Sutcliffe et 
al., 1992). Hypermethylation of the FMR1 region is associated with histone deacetylation, 
H3K9 methylation and chromatin remodeling, which may impact upon FMR1 transcription 
(Coffee et al., 1999; Coffee et al., 2002). However, it is suggested that DNA methylation, 
rather than histone modifications, is the key event for silencing of FMR1 transcription 
(Pietrobono et al., 2002; Pietrobono et al., 2005). In contrast to FRAXA, the unmethylated 55-
200 CGG repeats of the FMR1 gene that characterize FXTAS produce a 2-10 fold increase of 
FMR1 transcription, leading to an RNA toxic gain-of-function disease effect (Tassone et al., 
2000). For DM1, the expanded CTG repeat, which is situated in the 3-UTR of the DMPK 
gene, induces CpG methylation and H3K9 methylation flanking the repeat. This then 
silences transcription of DMPK and the neighbouring SIX5 and DMWD genes (Klesert et al., 
1997; Thornton et al., 1997; Alwazzan et al., 1999; Eriksson et al., 2001), likely by mechanisms 
that involve bidirectional transcription and siRNA formation (Cho et al., 2005). For FRDA, 
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the expanded GAA repeat within intron 1 of the FXN gene induces CpG methylation, 
histone deacetylation and H3K9 methylation in the region immediately upstream of the 
GAA repeat, but the FXN promoter appears to be unaffected (Greene et al., 2003; Herman et 
al., 2006; Al-Mahdawi et al., 2008). Since DNA methylation within the body of a gene has not 
been linked to transcriptional silencing (Brenet et al., 2011), it is unlikely that CpG 
methylation within intron 1 is the primary cause of FXN gene silencing. The increased DNA 
methylation within intron 1 of the FXN gene is more likely to be secondary to gene silencing 
caused by chromatin changes (Greene et al., 2007) or changes in bidirectional transcription 
and CTCF binding (De Biase et al., 2009). 
4.2 Modulation of TNR instability 
Another major effect of DNA methylation, specifically related to TNR expansion disorders, 
is the ability to influence the dynamics of the trinucleotide repeat stability. Both germline 
and somatic instability of TNR sequences are known to play major roles in the aetiology and 
progression of all TNR expansion disorders (Lopez Castel et al., 2010a). For FRAXA, 
germline instability of the CGG repeat involves maternally derived expansions, but deletion 
in the gametes of full-mutation males. The CGG deletions occur during replication and are 
dependent on replication fork dynamics, size of repeat and CpG methylation status (Nichol 
Edamura et al., 2005). The period of somatic CGG instability is restricted to early stages of 
embryonic and foetal growth and ends when expanded CGG sequences become abnormally 
methylated (Devys et al., 1992; Taylor et al., 1999).  Subsequent CpG methylation of FRAXA 
‘full mutation’ expanded CGG repeats causes somatic stability (Wohrle et al., 1995). Several 
studies, which have examined the effect of DNA methylation on germline TNR instability 
using mouse models of DM1, HD and SCA1, find that instability is particularly associated 
with periods of demethylation in the developing germline (Kaytor et al., 1997; Kovtun & 
McMurray, 2001; Savouret et al., 2004). Furthermore, treatment of cultured cells from DM1 
patients with DNA demethylating compounds produced destabilization of CTG repeats, 
with a bias towards expansion (Gorbunova et al., 2004). Thus, it appears that changes in 
DNA methylation patterns during germline epigenetic reprogramming may trigger the 
intergenerational TNR expansions that lead to disease. It is currently not known how DNA 
methylation stabilizes germline TNR sequences. However, several hypotheses have been 
proposed. For example, a recent study of heterozygous DNA methyltransferase 1 (Dnmt1+/-) 
knockout SCA1 mice revealed Dnmt1-deficient promotion of CAG intergenerational 
instability, together with aberrant DNA methylation and histone methylation within the 
CpG island adjacent to the CAG repeat, suggesting a role for local chromatin structure in 
germline TNR instability. However, no effect of Dnmt1 deficit was seen on somatic 
instability (Dion et al., 2008). Another study, which investigated somatic instability of the 
DM1 CTG repeat in relation to replication and CTCF binding, has led to the suggestion that 
CpG methylation may regulate, in a tissue-specific manner, the role of CTCF in DNA 
replication and thereby CTG repeat instability (Cleary et al., 2010). Yet another connection 
between DNA methylation, CTCF and TNR expansion has been identified in studies of 
SCA7 transgenic mice, which revealed further destabilization of unstable expanded CAG 
repeats by CpG methylation of CTCF binding sites (Libby et al., 2008). Furthermore, other 
studies suggest a potential connection between DNA methylation, transcription and TNR 
instability. For example, cyclical changes in promoter CpG methylation have been identified 
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during transcription (Kangaspeska et al., 2008; Metivier et al., 2008), and at the same time, 
transcription through the repeat tract has been identified as a major contributor to 
expansion of GAA repeats (Ditch et al., 2009). Therefore, periods of active demethylation 
during transcription may present a window of opportunity for TNR expansion. Finally, 
several studies have highlighted an important role of DNA repair mechanisms, and in 
particular the mismatch repair (MMR) system, in TNR instability (Savouret et al., 2003; 
Wheeler et al., 2003; Dragileva et al., 2009), and DNMT1 deficiency has been shown to result 
in MMR defects that increase the rate of CAG repeat contraction (Lin & Wilson, 2009). 
Therefore, it may be interesting to further pursue connections between DNA methylation, 
DNA repair and TNR instability. 
5. Demethylation therapy for TNR expansion diseases 
The finding that DNA methylation of the CGG repeat and flanking CpG sequences of the 
FMR1 promoter cause transcriptional silencing of the FMR1 gene in FRAXA, has lead to 
consideration of DNA demethylation as a potential therapy. To date, investigations have 
focused on the use of the cytidine analogue DNA methyltransferase inhibitor 5-aza-2’-
deoxycytidine (5-aza-CdR), which is an FDA approved drug (decitabine) used for the 
treatment of myelodysplastic anaemia (Oki et al., 2007). Treatment of fully methylated 
FRAXA patient cell lines with 5-aza-CdR leads to a decrease in promoter CpG methylation, 
together with increased histone acetylation, decreased H3K9 methylation and increased 
H3K4 methylation, that result in an increase in FMR1 transcription (Chiurazzi et al., 1998; 
Pietrobono et al., 2002; Tabolacci et al., 2005). Combined treatment with 5-aza-CdR and 
histone deacetylase (HDAC) inhibitors have also been shown to produce a synergistic 
increase in FMR1 transcription (Chiurazzi et al., 1999). However, 5-aza-CdR is a drug that 
induces substantial cytotoxicity, and therefore the development and testing of other less 
toxic DNA methylation inhibitors, such as zebularine (Cheng et al., 2003) or hydralazine 
(Cornacchia et al., 1988) may be necessary before treatment for FRAXA can be considered 
further. Another potential adverse effect of DNA methylation inhibitor treatment that will 
have to be considered is the finding that DNA demethylation can induce TNR instability, 
with a bias towards expansions (Gorbunova et al., 2004), which may then negatively impact 
upon gene expression. 
6. Conclusions 
DNA methylation is a molecular process that is clearly associated with TNR expansion 
disorders, particularly those of the long non-coding repeat type. Recent studies have 
revealed common themes for TNR gene silencing, including bidirectional transcription, 
siRNA formation, CTCF binding, histone modifications and chromatin remodeling. 
However, the exact role that DNA methylation plays within TNR expansion disease 
pathogenesis remains uncertain and further investigations are still needed. At the same 
time, DNA methylation also appears to impact upon TNR instability, which is an important 
part of TNR expansion disease progression. Therefore, the interplay between DNA 
methylation, DNA replication, DNA repair and transcription will need particular 
investigation if future consideration can realistically be given to DNA demethylation 
therapies for TNR expansion disorders. 
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